Get started
Author

Gökhan Uçar

Observed names: G Ucar, G. Ucar, G. Uçar, G., Uçar, Gokhan Ucar, Gokhan Uçar, GÖKHAN UÇAR, Gökhan Ucar, Gökhan UÇAR, Ucar, Gokhan, UÇAR, GÖKHAN, Uçar, Gökhan, uçar, gökhan
Observed institutions: Dicle University, Trakya University, Ministry of Health, Ankara University, Dokuz Eylül University, Ankara Numune Eğitim ve Araştırma Hastanesi, Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi, Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Amerikan Hastanesi, Ankara Bilkent City Hospital, Ankara Etlik City Hospital, Gazi University
ORCID: 0000-0002-7649-1075
Observed ORCID: 0000-0002-7649-1075
OpenAlex ID: A5084659231
Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis
2023 · Yakup Ergun, Gokhan Ucar, et al. · Cancer Treatment Reviews · 67
Scientific papers presented at the 2000–2001 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) meetings: publication rates during the period 2000–2004
2006 · Mustafa Secil, Gokhan Ucar, et al. · European Radiology · 42
Immunogenicity and Safety of the Coronavac Vaccine in Patients with Cancer Receiving Active Systemic Therapy
2021 · Cengiz Karacin, Tulay Eren, et al. · Future Oncology · 39
PDF
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
2019 · Hatime Arzu Yasar, Kadriye Bir Yucel, et al. · Journal of Oncology Pharmacy Practice · 27
Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients
2020 · Tulay Eren, Cengiz Karacin, et al. · Medicine · 25
Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
2020 · Gokhan Ucar, Yakup Ergun, et al. · Medicine · 24
The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer
2020 · Gokhan Ucar, Yakup Ergun, et al. · Asia-Pacific Journal of Clinical Oncology · 24
Elastography in Distinguishing Benign from Malignant Thyroid Nodules
2016 · Bulent Colakoglu, Duzgun Yildirim, et al. · Journal of Clinical Imaging Science · 21
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors
2022 · Kadriye Bir Yücel, Emre Yekedüz, et al. · Scientific Reports · 20
PDF
The combined use of brachial artery flow-mediated dilatation and carotid artery intima-media thickness measurements may be a method to determine vasculogenic erectile dysfunction
2007 · G Ucar, M Secil, et al. · International Journal of Impotence Research · 18
Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study.
2019 · Yakup Ergun, Nuriye Yildirim Ozdemir, et al. · PubMed · 16
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
2020 · Mutlu Hizal, Mehmet AN Sendur, et al. · Journal of Oncology Pharmacy Practice · 14
Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
2020 · Yakup Ergun, Oznur Bal, et al. · Journal of Research in Medical Sciences · 14
Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer
2023 · Selin Akturk Esen, Yigit Mehmet Ozgun, et al. · Oncology · 11
Efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive breast cancer: a systematic review and meta-analysis
2023 · Yakup Ergun, Mutlu Dogan, et al. · Expert Opinion on Pharmacotherapy · 10
The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis
2023 · Yakup Ergun, Baran Akagunduz, et al. · Clinical Breast Cancer · 10
Gastric Cancer Patients with Bone Marrow Metastasis: A Single-Center Experience and Review of the Literature
2017 · Yakup Ergun, Dogan Uncu, et al. · Eurasian Journal of Medicine and Oncology · 10
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer
2019 · Yakup Ergun, Yusuf Acikgoz, et al. · Expert Review of Molecular Diagnostics · 9
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy
2024 · Yusuf Ilhan, Gokhan Ucar, et al. · Expert Opinion on Pharmacotherapy · 8
The effect of chemotherapy on olfactory function and mucociliary clearance
2020 · Fakih Cihat Eravcı, Gökhan Uçar, et al. · Supportive Care in Cancer · 8
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database
2022 · Emre Yekedüz, Serdar Karakaya, et al. · Clinical Genitourinary Cancer · 7
Nivolumab in Metastatic Renal Cell Carcinoma: Results from the Turkish Oncology Group Kidney Cancer Consortium Database
2021 · Emre Yekedüz, İsmail Ertürk, et al. · Future Oncology · 7
Could Sarcopenia Be Related to Chemotherapy in Gastrointestinal Cancer? A Cross-Sectional Study Including Comprehensive Geriatric Assessment
2025 · Kamile Silay, Gokhan Ucar, et al. · Journal of Clinical Medicine · 6
PDF
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group
2024 · Arif Akyildiz, Melis Gultekin, et al. · International Journal of Gynecological Cancer · 6
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study
2023 · Okan Oktar, Vakkas Korkmaz, et al. · Journal of Gynecologic Oncology · 6
PDF
Works count: 111
Citation count: 558
H-index: 13
I10-index: 17
Year
Topic
Type